Tissue-type plasminogen activator and neuroserpin: A well-balanced act in the nervous system?

Trends in Cardiovascular Medicine

Volumn 14, Issue 5, 2004, Pages 173-180

  Yepes, Manuel ^a,b   Lawrence, Daniel A ^a  

^a HOLLAND LABORATORY   (United States)

^b GEORGETOWN UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMINOGEN ACTIVATOR; SERINE PROTEINASE INHIBITOR;

BLOOD BRAIN BARRIER; BLOOD VESSEL PERMEABILITY; BRAIN ISCHEMIA; BRAIN REGION; CELL DEATH; HUMAN; LEARNING; MEMORY; MULTIPLE SCLEROSIS; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM; NONHUMAN; PERIPHERAL NERVE INJURY; PLASMINOGEN ACTIVATION; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SEIZURE; SYNAPSE;

BRAIN; HUMANS; MYOCARDIAL ISCHEMIA; NEUROPEPTIDES; SEIZURES; SERPINS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 3242688902     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2004.03.004     Document Type: Review

References (49)

1. Akassoglou K, Kombrinck KW, Degen JL, Strickland S: 2000. Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury. J Cell Biol 149(5):1157-1166.
2. Aoki T, Sumii T, Mori T, et al.: 2002. Blood-brain barrier disruption and matrix metalloproteinase-9 expression during reperfusion injury: mechanical versus embolic focal ischemia in spontaneously hypertensive rats. Stroke 33(11):2711-2717.
3. Asahi M, Asahi K, Jung JC, et al.: 2000. Role for matrix metalloproteinase 9 after focal cerebral ischemia: effects of gene knockout and enzyme inhibition with BB-94. J Cereb Blood Flow Metab 20(12):1681-1689.
4. Asahi M, Wang X, Mori T, et al.: 2001. Effects of matrix metalloproteinase-9 gene knockout on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 21(19):7724-7732.
5. Baranes D, Lederfein D, Huang YY, et al.: 1998. Tissue plasminogen activator contributes to the late phase of LTP and to synaptic growth in the hippocampal mossy fiber pathway. Neuron 21(4):813-825.
6. Berger P, Kozlov SV, Cinelli P, et al.: 1999. Neuronal depolarization enhances the transcription of the neuronal serine protease inhibitor neuroserpin. Mol Cell Neurosci 14(6):455-467.
7. Bu G, Williams S, Strickland DK, Schwartz AL: 1992. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator. Proc Natl Acad Sci USA 89(16):7427-7431.
8. Carroll PM, Tsirka SE, Richards WG, et al.: 1994. The mouse tissue plasminogen activator gene 5′ flanking region directs appropriate expression in development and a seizure-enhanced response in the CNS. Development 120(11):3173-3183.
9. Cinelli P, Madani R, Tsuzuki N, et al.: 2001. Neuroserpin, a neuroprotective factor in focal ischemic stroke. Mol Cell Neurosci 18 (5):443-457.
10. Gualandris A, Jones TE, Strickland S, Tsirka SE: 1996. Membrane depolarization induces calcium-dependent secretion of tissue plasminogen activator. J Neurosci 16(7):2220-2225.
11. Gveric D, Herrera B, Petzold A, et al.: 2003. Impaired fibrinolysis in multiple sclerosis: a role for tissue plasminogen activator inhibitors. Brain 126(Pt 7):1590-1598.
12. Hastings GA, Coleman TA, Haudenschild CC, et al.: 1997. Neuroserpin, a brain-associated inhibitor of tissue plasminogen activator is localized primarily in neurons. Implications for the regulation of motor learning and neuronal survival. J Biol Chem 272 (52):33,062-33,067.
13. Huang YY, Bach ME, Lipp HP, et al.: 1996. Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathways. Proc Natl Acad Sci USA 93(16):8699-8704.
14. Jiang X, Wang Y, Hand AR, et al.: 2002. Storage and release of tissue plasminogen activator by sympathetic axons in resistance vessel walls. Microvasc Res 64(3):438-447.
15. Krueger SR, Ghisu GP, Cinelli P, et al.: 1997. Expression of neuroserpin, an inhibitor of tissue plasminogen activator, in the developing and adult nervous system of the mouse. J Neurosci 17(23):8984-8996.
16. Krystosek A, Seeds NW: 1981. Plasminogen activator release at the neuronal growth cone. Science 213(4515):1532-1534.
17. Levin EG, del Zoppo GJ: 1994. Localization of tissue plasminogen activator in the endothelium of a limited number of vessels. Am J Pathol 144(5):855-861.
18. Madani R, Kozlov S, Akhmedov A, et al.: 2003. Impaired explorative behavior and neophobia in genetically modified mice lacking or overexpressing the extracellular serine protease inhibitor neuroserpin. Mol Cell Neurosci 23(3):473-494.
19. Marler JR, Goldstein LB: 2003. Medicine. Stroke - tPA and the clinic. Science 301 (5640):1677.
20. Matys T, Strickland S: 2003. Tissue plasminogen activator and NMDA receptor cleavage. Nat Med 9(4):371-372.
21. Muller CM, Griesinger CB: 1998. Tissue plasminogen activator mediates reverse occlusion plasticity in visual cortex. Nat Neurosci 1(1):47-53.
22. Nagai N, De Mol M, Lijnen HR, et al.: 1999. Role of plasminogen system components in focal cerebral ischemic infarction: a gene targeting and gene transfer study in mice. Circulation 99(18):2440-2444.
23. Nassar T, Akkawi S, Shina A, et al.: 2004. The in vitro and in vivo effect of tPA and PAI-1 on blood vessel tone. Blood 103:897-902.
24. National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group:1995-Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333(24):1581-1587.
25. Nicole O, Docagne F, Ali C, et al.: 2001. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nat Med 7(1):59-64.
26. Osterwalder T, Contartese J, Stoeckli ET, et al.: 1996. Neuroserpin, an axonally secreted serine protease inhibitor. EMBO J 15(12):2944-2953.
27. Osterwalder T, Cinelli P, Baici A, et al.: 1998. The axonally secreted serine proteinase inhibitor, neuroserpin, inhibits plasminogen activators and plasmin but not thrombin. J Biol Chem 273(4):2312-2321.
28. Parmar PK, Coates LC, Pearson JF, et al.: 2002. Neuroserpin regulates neurite outgrowth in nerve growth factor-treated PC12 cells. J Neurochem 82(6):1406-1415.
29. Pawlak R, Magarinos AM, Melchor J, et al.: 2003. Tissue plasminogen activator in the amygdala is critical for stress-induced anxiety-like behavior. Nat Neurosci 6(2):168-174.
30. Qian Z, Gilbert ME, Colicos MA, et al.: 1993. Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 361(6411):453-457.
31. Rosenberg GA, Navratil M, Barone F, Feuerstein G: 1996. Proteolytic cascade enzymes increase in focal cerebral ischemia in rat. J Cereb Blood Flow Metab 16(3):360-366.
32. Salles FJ, Strickland S: 2002. Localization and regulation of the tissue plasminogen activator-plasmin system in the hippocampus. J Neurosci 22(6):2125-2134.
33. Sappino AP, Madani R, Huarte J, et al.: 1993. Extracellular proteolysis in the adult murine brain. J Clin Invest 92(2):679-685.
34. Schrimpf SP, Bleiker AJ, Brecevic L, et al.: 1997. Human neuroserpin (PI12): cDNA cloning and chromosomal localization to 3q26. Genomics 40(1):55-62.
35. Seeds NW, Basham ME, Ferguson JE: 2003. Absence of tissue plasminogen activator gene or activity impairs mouse cerebellar motor learning. J Neurosci 23(19):7368-7375.
36. Siao CJ, Fernandez SR, Tsirka SE: 2003. Cell type-specific roles for tissue plasminogen activator released by neurons or microglia after excitotoxic injury. J Neurosci 23(8):3224-3242.
37. Siconolfi LB, Seeds NW: 2003. Mice lacking tissue plasminogen activator and urokinase plasminogen activator genes show attenuated matrix metalloproteases activity after sciatic nerve crush. J Neurosci Res 74(3):430-434.
38. Tabrizi P, Wang L, Seeds N, et al.: 1999. Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model: studies in tPA-deficient mice and wild-type mice on a matched genetic background. Arterioscler Thromb Vasc Biol 19 (11):2801-2806.
39. Tsirka SE, Gualandris A, Amaral DG, Strickland S: 1995. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377 (6547):340-344.
40. Tsirka SE, Bugge TH, Degen JL, Strickland S: 1997a. Neuronal death in the central nervous system demonstrates a non-fibrin substrate for plasmin. Proc Natl Acad Sci USA 94(18):9779-9781.
41. Tsirka SE, Rogove AD, Bugge TH, et al.: 1997b. An extracellular proteolytic cascade promotes neuronal degeneration in the mouse hippocampus. J Neurosci 17(2):543-552.
42. Wang X, Lee SR, Arai K, et al.: 2003. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med 9(10):1313-1317.
43. Wang YF, Tsirka SE, Strickland S, et al.: 1998. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nat Med 4(2):228-231.
44. Ware JH, DiBenedetto AJ, Pittman RN: 1995. Localization of tissue plasminogen activator mRNA in the developing rat cerebellum and effects of inhibiting tissue plasminogen activator on granule cell migration. J Neurobiol 28(1):9-22.
45. Yepes M, Sandkvist M, Wong MK, et al.: 2000. Neuroserpin reduces cerebral infarct volume and protects neurons from ischemiainduced apoptosis. Blood 96(2):569-576.
46. Yepes M, Sandkvist M, Coleman TA, et al.: 2002. Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent. J Clin Invest 109(12):1571-1578.
47. Yepes M, Sandkvist M, Moore EG, et al.: 2003. Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein. J Clin Invest 112(10):1533-1540.
48. Zhang Z, Zhang L, Yepes M, et al.: 2002. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke. Circulation 106(6):740-745.
49. Zivin JA, Fisher M, DeGirolami U, et al.: 1985. Tissue plasminogen activator reduces neurological damage after cerebral embolism. Science 230(4731):1289-1292.